Effects of bacterial lipopolysaccharide on the pharmacokinetics of DA-8159, a new erectogenic, in rats. 2005

Joo H Lee, and Yu C Kim, and Jong W Kwon, and Won B Kim, and Myung G Lee
College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, San 56-1, Shinlim-Dong, Kwanak-Gu, Seoul 151-742, South Korea.

Pharmacokinetic parameters of DA-8159 and one of its metabolites, DA-8164, were compared after intravenous and oral administration of DA-8159 at a dose of 30 mg/kg to control rats and rats pretreated with Klebsiella pneumoniae lipopolysaccharide (KPLPS). After intravenous and oral administration of DA-8159, most of the pharmacokinetic parameters of DA-8159 and DA-8164 were not significantly different between two groups of rats. This suggested that the pharmacokinetic parameters of DA-8159 and DA-8164 were not affected considerably by KPLPS.

UI MeSH Term Description Entries
D007172 Erectile Dysfunction The inability in the male to have a PENILE ERECTION due to psychological or organ dysfunction. Impotence,Male Impotence,Male Sexual Impotence,Dysfunction, Erectile,Impotence, Male,Impotence, Male Sexual,Sexual Impotence, Male
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007711 Klebsiella pneumoniae Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans. Bacillus pneumoniae,Bacterium pneumoniae crouposae,Hyalococcus pneumoniae,Klebsiella pneumoniae aerogenes,Klebsiella rhinoscleromatis
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008297 Male Males
D010726 Phosphodiesterase Inhibitors Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. Phosphodiesterase Antagonists,Phosphodiesterase Inhibitor,Phosphoric Diester Hydrolase Inhibitors,Antiphosphodiesterases,Inhibitor, Phosphodiesterase
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011687 Purines A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.

Related Publications

Joo H Lee, and Yu C Kim, and Jong W Kwon, and Won B Kim, and Myung G Lee
October 2000, Archives of pharmacal research,
Joo H Lee, and Yu C Kim, and Jong W Kwon, and Won B Kim, and Myung G Lee
April 2008, British journal of pharmacology,
Joo H Lee, and Yu C Kim, and Jong W Kwon, and Won B Kim, and Myung G Lee
December 2002, Archives of pharmacal research,
Joo H Lee, and Yu C Kim, and Jong W Kwon, and Won B Kim, and Myung G Lee
June 2007, International journal of pharmaceutics,
Joo H Lee, and Yu C Kim, and Jong W Kwon, and Won B Kim, and Myung G Lee
May 2007, British journal of pharmacology,
Joo H Lee, and Yu C Kim, and Jong W Kwon, and Won B Kim, and Myung G Lee
January 2004, Arzneimittel-Forschung,
Joo H Lee, and Yu C Kim, and Jong W Kwon, and Won B Kim, and Myung G Lee
November 1993, The Journal of pharmacy and pharmacology,
Joo H Lee, and Yu C Kim, and Jong W Kwon, and Won B Kim, and Myung G Lee
May 2006, Asian journal of andrology,
Joo H Lee, and Yu C Kim, and Jong W Kwon, and Won B Kim, and Myung G Lee
August 2003, Archives of pharmacal research,
Joo H Lee, and Yu C Kim, and Jong W Kwon, and Won B Kim, and Myung G Lee
May 2012, Archives of pharmacal research,
Copied contents to your clipboard!